Life Technologies completes and settles previously announced Senior Notes offering

Life Technologies Corporation (NASDAQ: LIFE) today announced it has completed and settled the previously announced offering of $250 million aggregate principal amount of 3.375% Senior Notes due 2013 at an issue price of 99.953 percent; $500 million aggregate principal amount of 4.400% Senior Notes due 2015 at an issue price of 99.668 percent; and $750 million aggregate principal amount of 6.000% Senior Notes due 2020 at an issue price of 99.796 percent. The notes will pay interest on a semi-annual basis.

The proceeds of the offering will be used, together with cash on hand, to repay and retire the outstanding indebtedness under the term loan A facility and the term loan B facility of the company’s credit agreement. As of December 31, 2009, the company had $1.33 billion outstanding under the term loan A facility and $643 million outstanding under the term loan B facility.

Subject to the risk factors detailed in the Safe Harbor Statement section of this release, fiscal year 2010 interest expense is now expected to be between $110 million and $120 million, including amortization of debt issuance costs. Full year non-GAAP earnings per share guidance is still expected to be $3.30 - $3.50 as communicated on the company’s fourth quarter and full year 2009 earnings call.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.